A new IL-12 Immunotherapy Study for Dogs with Soft Tissue Sarcoma

$ 25.99

4.5
(137)
In stock
Description

Cancers, Free Full-Text

NK cell-based immunotherapy for malignant diseases

Cells, Free Full-Text

Animals, Free Full-Text

Optogenetic-controlled immunotherapeutic designer cells for post

Tumor-localized interleukin-2 and interleukin-12 combine with

Canine Sarcoma: An Overview of Cancer Immunotherapy

Immunohistological staining of canine IL-12 in tumors. a

Oncolytic virotherapy with intratumoral injection of vaccinia